Quick answers
- What is GLYDO- lidocaine hydrochloride jelly?
- GLYDO- lidocaine hydrochloride jelly is a brand name of Lidocaine, a prescription medicine. The FDA NDC Directory lists 1 GLYDO- lidocaine hydrochloride jelly product in 1 strength and form.
- Who makes GLYDO- lidocaine hydrochloride jelly?
- Sagent Pharms Inc holds the FDA application for GLYDO- lidocaine hydrochloride jelly (ANDA201094, approved April 28, 2014).
- Is there a generic or store brand of GLYDO- lidocaine hydrochloride jelly?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a GLYDO- lidocaine hydrochloride jelly product, 1 of them generic. Ask your pharmacist whether one is right for you.
- Has GLYDO- lidocaine hydrochloride jelly been recalled?
- No recall linked to GLYDO- lidocaine hydrochloride jelly products (by their NDC code or label) appears in the FDA enforcement reports we use.
What GLYDO- lidocaine hydrochloride jelly is
Each GLYDO- lidocaine hydrochloride jelly product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lidocaine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lidocaine hydrochloride anhydrous 20 mg/mL jelly (topical) | GLYDO- lidocaine hydrochloride jelly | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lidocaine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA201094 | Sagent Pharms Inc | April 28, 2014 | 1 |
Companies that list GLYDO- lidocaine hydrochloride jelly
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of GLYDO- lidocaine hydrochloride jelly products.
Recalls
No recall linked to GLYDO- lidocaine hydrochloride jelly products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.